NPA Celebrates Legal Victory in NMN Case

The NPA hailed the court’s decision to stay the NMN lawsuit as a “monumental victory,” emphasizing that the FDA exceeded its authority and must adhere to the law’s provisions. The ruling allows NMN supplements to remain on the market while the FDA reviews the citizen petition.

FDA Declares NMN Not a Legal Dietary Ingredient

The FDA announced that β-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, citing its prior investigation as a drug. The Council for Responsible Nutrition (CRN) responded, expressing concern that this decision stifles innovation and disregards consumer interests.